HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison.

AbstractBACKGROUND:
Cognitive behavioral therapy (CBT) and certain medications have been shown to be effective for binge eating disorder (BED), but no controlled studies have compared psychological and pharmacological therapies. We conducted a randomized, placebo-controlled study to test the efficacy of CBT and fluoxetine alone and in combination for BED.
METHODS:
108 patients were randomized to one of four 16-week individual treatments: fluoxetine (60 mg/day), placebo, CBT plus fluoxetine (60 mg/day) or CBT plus placebo. Medications were provided in double-blind fashion.
RESULTS:
Of the 108 patients, 86 (80%) completed treatments. Remission rates (zero binges for 28 days) for completers were: 29% (fluoxetine), 30% (placebo), 55% (CBT+fluoxetine), and 73% (CBT+placebo). Intent-to-treat (ITT) remission rates were: 22% (fluoxetine), 26% (placebo), 50% (CBT+fluoxetine), and 61% (CBT+placebo). Completer and ITT analyses on remission and dimensional measures of binge eating, cognitive features, and psychological distress produced consistent findings. Fluoxetine was not superior to placebo, CBT+fluoxetine and CBT+placebo did not differ, and both CBT conditions were superior to fluoxetine and to placebo. Weight loss was modest, did not differ across treatments, but was associated with binge eating remission.
CONCLUSIONS:
CBT, but not fluoxetine, demonstrated efficacy for the behavioral and psychological features of BED, but not obesity.
AuthorsCarlos M Grilo, Robin M Masheb, G Terence Wilson
JournalBiological psychiatry (Biol Psychiatry) Vol. 57 Issue 3 Pg. 301-9 (Feb 01 2005) ISSN: 0006-3223 [Print] United States
PMID15691532 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antidepressive Agents, Second-Generation
  • Fluoxetine
Topics
  • Adult
  • Antidepressive Agents, Second-Generation (therapeutic use)
  • Bulimia (therapy)
  • Cognitive Behavioral Therapy (methods)
  • Cross-Over Studies
  • Double-Blind Method
  • Female
  • Fluoxetine (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Secondary Prevention
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: